Benzamide riboside induced mitochondrial mediated apoptosis in human lung cancer H520 cells

Neeru Khanna, H. N. Jayaram, Neeta Singh

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Benzamide riboside (BR) is a novel anticancer agent exhibiting pronounced activity against several human tumor cell lines via the inhibition of inosine 5′-monophosphate dehydrogenase (IMPDH), thereby restricting the biosynthesis of guanylates. Although it has been demonstrated that BR inhibits IMPDH and induces apoptosis, however, not much attention has been directed to the mechanism of apoptosis induction by this compound. The purpose of the present investigation was to investigate the mechanism of cytotoxicity induced by BR in human lung cancer cells. Non-small cell lung cancer [NSCLC] is the most prevalent type of lung cancer especially in India, and displays resistance to anticancer treatment. The results reveal that BR at a dose of 50 μM induces apoptosis in NSCLC H520 cells. This was ascertained by alteration in cellular morphology, TUNEL assay and flow cytometry. While Bax protein level was unaffected there was down regulation of anti-apoptotic Bcl-2 protein and up regulation of p53 as observed by Western blotting. Induction of apoptosis was accompanied by significant increase in caspase-3 activity. BR is a potent growth inhibitory pro-drug rationally synthesized to mimic NAD and inhibits PARP at high concentrations when assayed in permeabilized leukemic cells. Our observations showed that increased caspase-3 activity was accompanied by PARP cleavage. We also observed release of cytochrome c from mitochondria to the cytosol whereas no change was seen in the levels of apoptosis inducing factor (AIF). These findings indicate that BR induces apoptosis in H520 cells via the intrinsic mitochondrial pathway.

Original languageEnglish
Pages (from-to)179-190
Number of pages12
JournalLife Sciences
Volume75
Issue number2
DOIs
StatePublished - May 28 2004

Fingerprint

Lung Neoplasms
Apoptosis
IMP Dehydrogenase
Cells
Non-Small Cell Lung Carcinoma
Caspase 3
Apoptosis Inducing Factor
bcl-2-Associated X Protein
Mitochondria
Flow cytometry
Biosynthesis
In Situ Nick-End Labeling
Prodrugs
Cytotoxicity
Cytochromes c
Tumor Cell Line
Antineoplastic Agents
NAD
Cytosol
3-(1-deoxyribofuranosyl)benzamide

Keywords

  • Apoptosis
  • Benzamide riboside
  • Caspases
  • Cytochrome C
  • H520 cells
  • Mitochondria

ASJC Scopus subject areas

  • Pharmacology

Cite this

Benzamide riboside induced mitochondrial mediated apoptosis in human lung cancer H520 cells. / Khanna, Neeru; Jayaram, H. N.; Singh, Neeta.

In: Life Sciences, Vol. 75, No. 2, 28.05.2004, p. 179-190.

Research output: Contribution to journalArticle

Khanna, Neeru ; Jayaram, H. N. ; Singh, Neeta. / Benzamide riboside induced mitochondrial mediated apoptosis in human lung cancer H520 cells. In: Life Sciences. 2004 ; Vol. 75, No. 2. pp. 179-190.
@article{4d8ea47820734c5d8c783f31669deb44,
title = "Benzamide riboside induced mitochondrial mediated apoptosis in human lung cancer H520 cells",
abstract = "Benzamide riboside (BR) is a novel anticancer agent exhibiting pronounced activity against several human tumor cell lines via the inhibition of inosine 5′-monophosphate dehydrogenase (IMPDH), thereby restricting the biosynthesis of guanylates. Although it has been demonstrated that BR inhibits IMPDH and induces apoptosis, however, not much attention has been directed to the mechanism of apoptosis induction by this compound. The purpose of the present investigation was to investigate the mechanism of cytotoxicity induced by BR in human lung cancer cells. Non-small cell lung cancer [NSCLC] is the most prevalent type of lung cancer especially in India, and displays resistance to anticancer treatment. The results reveal that BR at a dose of 50 μM induces apoptosis in NSCLC H520 cells. This was ascertained by alteration in cellular morphology, TUNEL assay and flow cytometry. While Bax protein level was unaffected there was down regulation of anti-apoptotic Bcl-2 protein and up regulation of p53 as observed by Western blotting. Induction of apoptosis was accompanied by significant increase in caspase-3 activity. BR is a potent growth inhibitory pro-drug rationally synthesized to mimic NAD and inhibits PARP at high concentrations when assayed in permeabilized leukemic cells. Our observations showed that increased caspase-3 activity was accompanied by PARP cleavage. We also observed release of cytochrome c from mitochondria to the cytosol whereas no change was seen in the levels of apoptosis inducing factor (AIF). These findings indicate that BR induces apoptosis in H520 cells via the intrinsic mitochondrial pathway.",
keywords = "Apoptosis, Benzamide riboside, Caspases, Cytochrome C, H520 cells, Mitochondria",
author = "Neeru Khanna and Jayaram, {H. N.} and Neeta Singh",
year = "2004",
month = "5",
day = "28",
doi = "10.1016/j.lfs.2003.11.026",
language = "English",
volume = "75",
pages = "179--190",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Benzamide riboside induced mitochondrial mediated apoptosis in human lung cancer H520 cells

AU - Khanna, Neeru

AU - Jayaram, H. N.

AU - Singh, Neeta

PY - 2004/5/28

Y1 - 2004/5/28

N2 - Benzamide riboside (BR) is a novel anticancer agent exhibiting pronounced activity against several human tumor cell lines via the inhibition of inosine 5′-monophosphate dehydrogenase (IMPDH), thereby restricting the biosynthesis of guanylates. Although it has been demonstrated that BR inhibits IMPDH and induces apoptosis, however, not much attention has been directed to the mechanism of apoptosis induction by this compound. The purpose of the present investigation was to investigate the mechanism of cytotoxicity induced by BR in human lung cancer cells. Non-small cell lung cancer [NSCLC] is the most prevalent type of lung cancer especially in India, and displays resistance to anticancer treatment. The results reveal that BR at a dose of 50 μM induces apoptosis in NSCLC H520 cells. This was ascertained by alteration in cellular morphology, TUNEL assay and flow cytometry. While Bax protein level was unaffected there was down regulation of anti-apoptotic Bcl-2 protein and up regulation of p53 as observed by Western blotting. Induction of apoptosis was accompanied by significant increase in caspase-3 activity. BR is a potent growth inhibitory pro-drug rationally synthesized to mimic NAD and inhibits PARP at high concentrations when assayed in permeabilized leukemic cells. Our observations showed that increased caspase-3 activity was accompanied by PARP cleavage. We also observed release of cytochrome c from mitochondria to the cytosol whereas no change was seen in the levels of apoptosis inducing factor (AIF). These findings indicate that BR induces apoptosis in H520 cells via the intrinsic mitochondrial pathway.

AB - Benzamide riboside (BR) is a novel anticancer agent exhibiting pronounced activity against several human tumor cell lines via the inhibition of inosine 5′-monophosphate dehydrogenase (IMPDH), thereby restricting the biosynthesis of guanylates. Although it has been demonstrated that BR inhibits IMPDH and induces apoptosis, however, not much attention has been directed to the mechanism of apoptosis induction by this compound. The purpose of the present investigation was to investigate the mechanism of cytotoxicity induced by BR in human lung cancer cells. Non-small cell lung cancer [NSCLC] is the most prevalent type of lung cancer especially in India, and displays resistance to anticancer treatment. The results reveal that BR at a dose of 50 μM induces apoptosis in NSCLC H520 cells. This was ascertained by alteration in cellular morphology, TUNEL assay and flow cytometry. While Bax protein level was unaffected there was down regulation of anti-apoptotic Bcl-2 protein and up regulation of p53 as observed by Western blotting. Induction of apoptosis was accompanied by significant increase in caspase-3 activity. BR is a potent growth inhibitory pro-drug rationally synthesized to mimic NAD and inhibits PARP at high concentrations when assayed in permeabilized leukemic cells. Our observations showed that increased caspase-3 activity was accompanied by PARP cleavage. We also observed release of cytochrome c from mitochondria to the cytosol whereas no change was seen in the levels of apoptosis inducing factor (AIF). These findings indicate that BR induces apoptosis in H520 cells via the intrinsic mitochondrial pathway.

KW - Apoptosis

KW - Benzamide riboside

KW - Caspases

KW - Cytochrome C

KW - H520 cells

KW - Mitochondria

UR - http://www.scopus.com/inward/record.url?scp=2142754435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2142754435&partnerID=8YFLogxK

U2 - 10.1016/j.lfs.2003.11.026

DO - 10.1016/j.lfs.2003.11.026

M3 - Article

VL - 75

SP - 179

EP - 190

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 2

ER -